Multidimensional effects of sertraline in social anxiety disorder

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Depression and Anxiety

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/da.20086PMID 16216019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia.

  2004cited by this paper
• Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study.

  2003influential reference
• Pathophysiology of sweating.

  2002cited by this paper
• Estrogen raises the sweating threshold in postmenopausal women with hot flashes.

  2002cited by this paper
• Hyperhidrosis in social anxiety disorder.

  2002cited by this paper
• Emotionally induced hyperhidrosis.

  2002cited by this paper
• Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.

  2001cited by this paper
• Botulinum toxin A for axillary hyperhidrosis (excessive sweating).

  2001cited by this paper
• Social fears and social phobia in a community sample of adolescents and young adults: prevalence, risk factors and co-morbidity

  1999cited by this paper
• Paroxetine in social phobia/social anxiety disorder

  1999cited by this paper
• Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.

  1998cited by this paper
• Successful treatment of facial blushing by endoscopic transthoracic sympathicotomy

  1998cited by this paper
• The Brief Social Phobia Scale: a psychometric evaluation

  1997cited by this paper
• Phenomenology of panic attacks: responsiveness of individual symptoms to imipramine.

  1996cited by this paper
• Endoscopic versus transaxillary thoracic sympathectomy for primary axillary and palmar hyperhidrosis and/or facial blushing: 5-year-experience.

  1996cited by this paper
• Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey.

  1996cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders, 4th Ed.

  1994cited by this paper
• Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

  1994cited by this paper
• Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey.

  1994cited by this paper
• [How erythrophobia became social phobia. An overview of the clinical-diagnostic topic].

  1992cited by this paper
• diagnostic and statistical manual of mental disorders,

  year unknowncited by this paper

• Navigating the Virtual Gaze: Social Anxiety's Role in VR Proxemics

  2024cites this paper
• Staged single-port thoracoscopic R2 sympathicotomy as a reproducible, safe and effective treatment option for debilitating severe facial blushing

  2022cites this paper
• OP-ICVA220261 1..5

  2022cites this paper
• Prevalence of Depression in Iranian College Students: A Systematic Review and Meta-analysis

  2021cites this paper
• The Epidemiology of Subjective Sleep Quality in the Citizens of Kermanshah, Iran

  2020cites this paper
• Treatment Options for Fear of Blushing

  2020cites this paper
• Reduced Reward Responsiveness Predicts Change in Depressive Symptoms in Anxious Children and Adolescents Following Treatment

  2019cites this paper
• Facial Blushing: Psychiatric Management

  2018cites this paper
• Therapeutic Effectiveness of Galphimia glauca in Young People with Social Anxiety Disorder: A Pilot Study

  2018cites this paper
• Cluster analysis profiling of behaviors in zebrafish larvae treated with antidepressants and pesticides.

  2017cites this paper
• Social blushing: a neuropsychiatric disorder?

  2016cites this paper
• Effects of Sleep Quality on the Academic Performance of Undergraduate Medical Students

  2016cites this paper
• Facial Blushing: Patient Selection and Long-Term Results.

  2016cites this paper
• Blushing and Social Anxiety: A Meta‐Analysis

  2015cites this paper
• Blushing and Social Anxiety: A Meta-Analysis

  2015cites this paper
• Psychological and pharmacological interventions for social anxiety disorder in adults: a systematic review and network meta-analysis

  2014cites this paper
• Long-term results of endoscopic symphathetic block using the Lin-Telaranta classification

  2013cites this paper
• Evaluation of the pharmacokinetics, safety and clinical efficacy of sertraline used to treat social anxiety

  2013cites this paper
• Fear, avoidance and physiological symptoms during cognitive-behavioral therapy for social anxiety disorder.

  2013cites this paper
• Open-Label Treatment With Escitalopram in Patients With Social Anxiety Disorder and Fear of Blushing

  2013influential citation
• [Efficacy of a cognitive-behavioral group therapy in patients with fear of blushing].

  2012cites this paper
• Social anxiety and functional impairment in patients seeking surgical evaluation for hyperhidrosis.

  2012cites this paper
• Tratamentos farmacológicos para o transtorno de ansiedade social: existem novos parâmetros na atualidade?

  2011cites this paper
• Social anxiety disorder: radio electric asymmetric conveyor brain stimulation versus sertraline

  2011cites this paper
• Evaluating the efficacy of endoscopic thoracic sympathectomy for generalized social anxiety disorder with blushing complaints: a comparison with sertraline and no treatment-santiago de chile 2003-2009.

  2011cites this paper
• Pharmacotherapy of social anxiety disorder

  2011cites this paper
• social anxiety disorder: radio electric asymmetric conveyor brain stimulation versus sertraline

  2011cites this paper
• Anxiety Disorders: Is there a spectrum of social anxiety disorder?

  2010cites this paper
• Sociodemographic and health-related risks for loneliness and outcome differences by loneliness status in a sample of U.S. older adults.

  2010cites this paper
• Can a one-weekend group therapy reduce fear of blushing? Results of an open trial

  2010cites this paper
• Social anxiety disorder: questions and answers for the DSM‐V

  2010cites this paper
• Genetic contributions of the serotonin transporter to social learning of fear and economic decision making.

  2009cites this paper
• The neural correlates of blushing : Piloting an elicitation protocol

  2009cites this paper
• An evidence-based review of the clinical use of sertraline in mood and anxiety disorders.

  2009influential citation
• Blushing propensity in social anxiety disorder: influence of serotonin transporter gene variation

  2009cites this paper
• Efectos secundarios de los ISRS sin importancia para la salud que pueden contribuir al mal cumplimiento o al abandono del tratamiento

  2008cites this paper
• Social Anxiety Disorder

  2008cites this paper
• The Exposure Hierarchy as a Measure of Progress and Efficacy in the Treatment of Social Anxiety Disorder

  2008cites this paper
• Social Anxiety Disorder - A Review of Pharmacological Treatments

  2007cites this paper
• A 12-month comparison of brief psychodynamic psychotherapy and pharmacotherapy treatment in subjects with generalised anxiety disorders in a community setting

  2007cites this paper
• A 1-year follow-up study of chest-pain patients with and without panic disorder.

  2006cites this paper